ArticleBriefings in bioinformatics2026
APAdeg enhances differentially expressed gene inference by leveraging site-specific signals in APA-seq data.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Alternative polyadenylation (APA) is a key post-transcriptional regulatory mechanism implicated in various diseases. Existing APA analysis tools are generally restricted to site detection and comparison, precluding differently expressed gene (DEG) analysis. Furthermore, standard RNA-seq-based DEG methods, though commonly used for gene expression profiling, demonstrate limited efficacy in identifying DEGs when directly applied to APA-seq datasets. To address this limitation, we developed APAdeg, a novel statistical method specifically tailored for DEG analysis of APA-seq data. APAdeg integrates both the total read count of a gene and the site-specific read counts within the gene into a generalized linear mixed model, thereby improving the efficiency of DEG detection. Benchmarking analyses on both simulated and empirical APA-seq data demonstrated that APAdeg consistently outperforms RNA-seq-based methods in DEG inference. Application of APAdeg to APA-seq data from distinct cancer types revealed that only a small proportion of DEGs exhibited significant changes in 3' untranslated region length, with an equally small proportion showing significant alterations in intronic APA usage. To facilitate widespread adoption, we implemented APAdeg as an R package. Collectively, APAdeg significantly enhances the accuracy of DEG analysis from APA-seq data, thereby advancing research into APA-mediated gene regulation in diseases and health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.